Skip to main content

Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Publication ,  Journal Article
Miller, MJ; Cusmano-Ozog, K; Oglesbee, D; Young, S; ACMG Laboratory Quality Assurance Committee,
Published in: Genet Med
February 2021

Acylcarnitine analysis is a useful test for identifying patients with inborn errors of mitochondrial fatty acid β-oxidation and certain organic acidemias. Plasma is routinely used in the diagnostic workup of symptomatic patients. Urine analysis of targeted acylcarnitine species may be helpful in the diagnosis of glutaric acidemia type I and other disorders in which polar acylcarnitine species accumulate. For newborn screening applications, dried blood spot acylcarnitine analysis can be performed as a multiplex assay with other analytes, including amino acids, succinylacetone, guanidinoacetate, creatine, and lysophosphatidylcholines. Tandem mass spectrometric methodology, established more than 30 years ago, remains a valid approach for acylcarnitine analysis. The method involves flow-injection analysis of esterified or underivatized acylcarnitines species and detection using a precursor-ion scan. Alternative methods utilize liquid chromatographic separation of isomeric and isobaric species and/or detection by selected reaction monitoring. These technical standards were developed as a resource for diagnostic laboratory practices in acylcarnitine analysis, interpretation, and reporting.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Genet Med

DOI

EISSN

1530-0366

Publication Date

February 2021

Volume

23

Issue

2

Start / End Page

249 / 258

Location

United States

Related Subject Headings

  • United States
  • Laboratories
  • Infant, Newborn
  • Humans
  • Genomics
  • Genetics, Medical
  • Genetics & Heredity
  • Carnitine
  • 3105 Genetics
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Miller, M. J., Cusmano-Ozog, K., Oglesbee, D., Young, S., & ACMG Laboratory Quality Assurance Committee, . (2021). Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 23(2), 249–258. https://doi.org/10.1038/s41436-020-00990-1
Miller, Marcus J., Kristina Cusmano-Ozog, Devin Oglesbee, Sarah Young, and Sarah ACMG Laboratory Quality Assurance Committee. “Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).Genet Med 23, no. 2 (February 2021): 249–58. https://doi.org/10.1038/s41436-020-00990-1.
Miller MJ, Cusmano-Ozog K, Oglesbee D, Young S, ACMG Laboratory Quality Assurance Committee. Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 Feb;23(2):249–58.
Miller, Marcus J., et al. “Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).Genet Med, vol. 23, no. 2, Feb. 2021, pp. 249–58. Pubmed, doi:10.1038/s41436-020-00990-1.
Miller MJ, Cusmano-Ozog K, Oglesbee D, Young S, ACMG Laboratory Quality Assurance Committee. Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 Feb;23(2):249–258.

Published In

Genet Med

DOI

EISSN

1530-0366

Publication Date

February 2021

Volume

23

Issue

2

Start / End Page

249 / 258

Location

United States

Related Subject Headings

  • United States
  • Laboratories
  • Infant, Newborn
  • Humans
  • Genomics
  • Genetics, Medical
  • Genetics & Heredity
  • Carnitine
  • 3105 Genetics
  • 1103 Clinical Sciences